LHX vs RCUS · P/E 34, rev $5.88B vs rev $58.0M
L3Harris Technologies Inc (LHX) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Latest reported RCUS revenue for 2026-06-30 was $58.0M. Net income was -$219.0M. RCUS currently screens at market cap $885.2M.
LHX currently screens at market cap $58.72B and trailing P/E 34.3. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the LHX and RCUS stock pages for the full models.
Not investment advice.